NEPH

Conviction 77HealthcareScan · Mon, Aug 10, 2026

NEPH$4.61+9.38%

ResistanceSupportVol 14

Vol MA14 45.97K

May 11May 28Jun 16Jul 6Jul 23Aug 10

NEPHROS INCSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.nephros.com ↗

Price4.61

Change+9.38%

Gap+9.38%

Rel volume29.42×

Avg volume34.07K

Avg $ vol144.73K

SMA 203.66

SMA 503.52

SMA 2003.98

Price vs 50+30.91%

Price vs 200+15.79%

MA stackmixed

50/200 cross—

Supertrendup · 3.66

RSI (14)73

MACD hist0.09

MACD crossbull · 1d

Stoch %K / %D100 / 77

ADX (14)26

+DI / −DI35 / 8

RSI divergence—

MACD divergence—

ATR %+6.42%

ADR %6.73%

52w high5.79

52w low2.78

From 52w high-20.40%

Above 52w low+65.65%

New 52w highNo

SqueezeFired

Bollinger width31.32%

%B1.32

Donchian pos100.00%

Donchian high4.61

Donchian low3.20

AVWAP (52w high)4.10

vs AVWAP high+12.25%

AVWAP (52w low)3.59

vs AVWAP low+28.40%

OBV trendUp

Chaikin MF (20)0.13

Today vs 20d29.42×

Avg vol (14d)45.97K

Avg vol (20d)34.07K

Avg $ vol (20d)144.73K

Market cap—

RS 3m (vs SPY)+24.64%

RS 6m (vs SPY)-5.61%

RS line new highYes

Trend template5/8

Technical rank85.6

1 week+31.20%

1 month+26.86%

3 months+30.82%

6 months+18.99%

1 year+59.34%

YTD-3.05%

P/E38.78

P/B5.54

P/S2.46

P/FCF29.12

EPS0.1100

Div yield—

ROE14.29%

ROA8.66%

Debt/Eq0.07

Current4.55

EV/EBITDA36.79

Gross margin61.87%

Net margin6.35%

Rev growth32.67%

EPS growth1513.51%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value42.86M

Revenue5.21M

Net income140K

Gross profit2.99M

Free cash flow1.59M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out10.86M

Employees36

ListedTue, Sep 21, 2004

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction77 / 100

Pattern quality—

Tech rank85.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.85

Support3.15

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 1
1 scan
→
Breaking out now
Jul 16
1 scan

Congress activity

Disclosed STOCK Act trades in NEPH

All disclosures →

No recent disclosed trades by Congress in NEPH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NEPH · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Amron Arthur H Director · Common Stock · 2026-05-11	Grant	3.57K	—	2026-05-11	2026-06-12

SEC filings

EDGAR filings in NEPH · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.